Concern over removal of another opioid use disorder treatment
SYDNEY: US-based pharmaceutical company Indivior is planning to remove another opioid use disorder treatment, Subutex,
SYDNEY: US-based pharmaceutical company Indivior is planning to remove another opioid use disorder treatment, Subutex,
FEATURED
MUHSEN Australia first inaugural “Created with Purpose” disability conference
Housing innovation to attract elderly, young and disability client base
Insurer adds AI-backed virtual physiotherapy for disability claimants
Workplace adjustments employers should consider to support disabled workers
Employee loses dispute over disability-related WFH request
Is your email signoff up to date with an ADHD disclaimer?